NCT04883255View on ClinicalTrials.gov

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
HIV-1-infection
Interventions
DRUG

10 mg Δ9-tetrahydrocannabinol (THC)

5-day course of orally-administered THC (dronabinol), 10 mg

DRUG

600 mg cannabidiol (CBD)

5-day course of orally-administered CBD, 600 mg

DRUG

Placebo

5-day course of orally-administered placebo

Trial Locations (1)

92103-8620

RECRUITING

UC San Diego Medical Center-Hillcrest, San Diego

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, San Diego

OTHER